Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05962242 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma

Study acronym: HN001
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 1 of 5 sitesv5
  2. Study sites: 4 to 5v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2024 to Jun 28, 2024
    • Eligibility criteria expanded, about 18 words
    • Site details revised at 4 of 4 sites
    v3
  4. Start date: Sep 1, 2023 to Jan 1, 2024v2 Show 4 more changesShow less
    • Primary completion date: Sep 1, 2027 to Nov 1, 2027
    • Study completion date: Sep 1, 2029 to Nov 1, 2029
    • Eligibility criteria expanded, about 2 words
    • Study description expanded, about 3 words
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study will evaluate the safety and effectiveness of a lower than standard dose of radiation for definitive or adjuvant treatment of head and neck squamous cell carcinomas.
Trial Details
NCT Number NCT05962242
Lead Sponsor University of Virginia
Conditions
(from sponsor)		 Squamous Cell Carcinoma of the Oropharynx
Related terms Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov